VCV002579202.1 - ClinVar

GRCh38/hg38 13q33.3-34(chr13:106425676-114326445)x1

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

GRCh38/hg38 13q33.3-34(chr13:106425676-114326445)x1

Variation ID: 2579202 Accession: VCV002579202.1

Type and length

copy number loss, 7,900,770 bp

Location

Cytogenetic: 13q33.3-34 13: 106425676-114326445 (GRCh38) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Sep 16, 2023	Sep 16, 2023	Aug 24, 2023

HGVS

Protein change

Other names

Canonical SPDI

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
CHAMP1		Little evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	235	356
ABHD13	-	-	-	GRCh38 GRCh37	22	140
ADPRHL1		-	-	GRCh38 GRCh37	50	172
ANKRD10	-	-	-	GRCh38 GRCh37	23	136
ARGLU1		-	-	GRCh38 GRCh37	13	124
ARGLU1-DT	-	-	-	GRCh38	-	41
ARHGEF7		-	-	GRCh38 GRCh37	44	167
ARHGEF7-AS1	-	-	-	GRCh38	-	43
ARHGEF7-AS2	-	-	-	GRCh38	-	45
ATP11A		-	-	GRCh38 GRCh37	140	272

There are 304 more genes affected by this variant. See the full set of genes in Variation Viewer (GRCh38).

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Chromosome 13q33-q34 deletion syndrome	Pathogenic (1)	criteria provided, single submitter	Aug 24, 2023	RCV003327641.3

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Pathogenic (Aug 24, 2023)	criteria provided, single submitter (ACMG/ClinGen CNV Guidelines, 2019) Method: research	Chromosome 13q33-q34 deletion syndrome (Autosomal dominant inheritance) Affected status: yes Allele origin: unknown	Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard Accession: SCV004034177.1 First in ClinVar: Sep 16, 2023 Last updated: Sep 16, 2023	Publications: PubMed (3) PubMed: 31690835‚ 18203171‚ 32616040 Comment: A heterozygous deletion of 33 genes (https://genescout.omim.org/) was identified by exome sequencing in one individual with chromosome 13q33-q34 deletion syndrome ([GRCh 38] chr13:106425676_114326445x1). These breakpoints … (more) A heterozygous deletion of 33 genes (https://genescout.omim.org/) was identified by exome sequencing in one individual with chromosome 13q33-q34 deletion syndrome ([GRCh 38] chr13:106425676_114326445x1). These breakpoints have been estimated by exome sequencing only and therefore may not reflect the true breakpoints. Inheritance information is unavailable. The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. There is partial overlap with the 5’ end of the CHAMP1 gene including coding sequence, which has emerging evidence for haploinsufficiency, and has been assessed by the ClinGen Dosage Sensitivity Working Group. Two reported probands from the literature (PMID: 18203171, 32616040) have a copy-number loss in 13q33-q34 similar in genomic content to the variant in our study. The variants reported are assumed de novo and the reported phenotype is nonspecific. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant chromosome 13q33-q34 deletion syndrome. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 3: 0.45 points, 4: 0.2 points, 5: 0.1 points Total: 1.65 points; Riggs 2020 (PMID: 31690835). (less)

Comment:

A heterozygous deletion of 33 genes (https://genescout.omim.org/) was identified by exome sequencing in one individual with chromosome 13q33-q34 deletion syndrome ([GRCh 38] chr13:106425676_114326445x1). These breakpoints have been estimated by exome sequencing only and therefore may not reflect the true breakpoints. Inheritance information is unavailable. The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. There is partial overlap with the 5’ end of the CHAMP1 gene including coding sequence, which has emerging evidence for haploinsufficiency, and has been assessed by the ClinGen Dosage Sensitivity Working Group. Two reported probands from the literature (PMID: 18203171, 32616040) have a copy-number loss in 13q33-q34 similar in genomic content to the variant in our study. The variants reported are assumed de novo and the reported phenotype is nonspecific. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant chromosome 13q33-q34 deletion syndrome. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 3: 0.45 points, 4: 0.2 points, 5: 0.1 points Total: 1.65 points; Riggs 2020 (PMID: 31690835).

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Reduced anogenital distance, hematuria and left renal hypoplasia in a patient with 13q33.1-34 deletion: case report and literature review.	He X	BMC pediatrics	2020	PMID: 32616040
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).	Riggs ER	Genetics in medicine : official journal of the American College of Medical Genetics	2020	PMID: 31690835
Chromosome deletions in 13q33-34: report of four patients and review of the literature.	Walczak-Sztulpa J	American journal of medical genetics. Part A	2008	PMID: 18203171

Text-mined citations for this variant ...

Record last updated Jun 23, 2024

ClinVar Genomic variation as it relates to human health

GRCh38/hg38 13q33.3-34(chr13:106425676-114326445)x1

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...